Skip to main content
Membership NewsMembership News Archive

DHSC announces cervical screening self-sampling study results

The Department of Health and Social Care has announced publication of the final results from the HPValidate study, commissioned and funded by Public Health England to evaluate the accuracy and acceptability of self-sampling for HPV in comparison with standard clinician-taken cervical screening tests. The study was commissioned in response to a 2019 UK National Screening Committee recommendation that more evidence should be…
Ben Kemp
November 19, 2024
Membership NewsMembership News Archive

BIVDA at MEDICA

After a an extremely busy but enjoyable four days at MEDICA in Dusseldorf last week, we hope everyone is suitably rested yet energised by the opportunities the event presented. We would like to thank everyone who visited our stand and welcomed us to theirs. We greatly enjoyed meeting so many of our members, whose brilliant stands and innovations showcased the…
Ben Kemp
November 19, 2024
Membership NewsMembership News Archive

UK AMR infections surpass pre-pandemic levels

National surveillance data published by the UK Health Security Agency has shown that antibiotic resistant infections in 2023 surpassed pre-pandemic levels. There were an estimated 66,730 serious antibiotic resistant infections in 2023, compared to 62,314 in 2019. The English Surveillance of Antibiotic Prescribing and Utilisation Report (ESPAUR) shows that the majority of antibiotic resistant bloodstream infections in the last 5 years (65%)…
Ben Kemp
November 19, 2024
Membership NewsMembership News ArchiveRegulatory Affairs NewsletterRegulatory Affairs Newsletter ArchiveUK Government Updates Regulatory Affairs NewsletterUK Government Updates Regulatory Affairs Newsletter Archive

MHRA consultation on Medical Devices Regulations for routes to market and IVDs

The MHRA last week opened their consultation on Medical Devices Regulations for routes to market and in vitro diagnostic devices. This relates to the proposed pre-market Statutory Instrument which is planned to be laid before parliament next year. The MHRA are seeking views as a number of changes have occurred since they previously consulted last year. Areas are: -     International…
Ben Kemp
November 19, 2024
Other Updates Regulatory Affairs NewsletterOther Updates Regulatory Affairs Newsletter ArchiveRegulatory Affairs NewsletterRegulatory Affairs Newsletter Archive

CLSI C34 | Sweat Testing: Specimen Collection and Quantitative Chloride Analysis

Newly Released Screening & Collection Guidance   CLSI C34 | Sweat Testing: Specimen Collection and Quantitative Chloride Analysis Date of Publication: 8 November 2024 Price: $180 for PDF CLSI C34 describes methods for all aspects of sweat testing, including collection and analysis, results evaluation and reporting, and quality control. You can purchase it here.
Ben Kemp
November 14, 2024